Literature DB >> 12027197

Correlation of thymidine phosphorylase staining and the Ki-67 labeling index to clinicopathologic factors and hepatic metastasis in patients with colorectal cancer.

Toshiaki Kitabatake1, Kuniaki Kojima, Masaki Fukasawa, Tomoe Beppu, Shunji Futagawa.   

Abstract

PURPOSE: Our aim was to investigate the thymidine phosphorylase (TdRPase) expression and Ki-67 labeling index (LI) of primary tumors of colorectal cancer and hepatic metastases immunochemically and to evaluate the relationship of these parameters to various clinicopathologic factors and hepatic metastasis.
METHODS: We performed immunochemical studies in 74 patients with colorectal cancer, using anti-TdRPase antibody and MIB-1 antibody.
RESULTS: TdRPase expression and a Ki-67 LI > or =30% in primary lesions were significantly more common in patients with lymphatic invasion (ly), venous invasion (v), lymph node involvement (n), and hepatic metastasis. A Ki-67 LI > or = 30% of the primary tumor was associated with a significantly higher frequency of metachronous liver metastasis. In the same patients, the mean Ki-67 LI was 24.3+/-17.9 for primary lesions and 5.0+/-4.2 for hepatic metastases, this difference being significant.
CONCLUSIONS: These results indicate that TdRPase expression and the Ki-67 LI are related to various clinicopathologic factors, suggesting their usefulness as indices of tumor malignancy. We suggest that the Ki-67 LI of primary colorectal cancer could be an important predictor of the future development of metachronous liver metastasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027197     DOI: 10.1007/s005950200046

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  Mitochondrial DNA Integrity Is Maintained by APE1 in Carcinogen-Induced Colorectal Cancer.

Authors:  Joan Ballista-Hernández; Margaly Martínez-Ferrer; Roman Vélez; Consuelo Climent; Maria M Sánchez-Vázquez; Ceidy Torres; Adlin Rodríguez-Muñoz; Sylvette Ayala-Peña; Carlos A Torres-Ramos
Journal:  Mol Cancer Res       Date:  2017-03-30       Impact factor: 5.852

2.  Assessment of SMAD4, p53, and Ki-67 alterations as a predictor of liver metastasis in human colorectal cancer.

Authors:  Masayo Kawakami; Tatsuro Yamaguchi; Keiichi Takahashi; Hiroshi Matsumoto; Michiya Yasutome; Shinichiro Horiguchi; Yukiko Hayashi; Nobuaki Funata; Takeo Mori
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

3.  Interferon-beta inhibits liver metastases from murine colon 26 carcinoma and its highly metastatic variant.

Authors:  Shigechika Kohashi; Yuji Sato; Tsuyoshi Fukushima; Hiroki Shomura; Takahiro Oshima; Sun Bairun; Masao Kondo; Yoshie Une; Jun Nishihira; Satoru Todo
Journal:  Surg Today       Date:  2007-05-28       Impact factor: 2.549

Review 4.  The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.

Authors:  A A P Slesser; P Georgiou; G Brown; S Mudan; R Goldin; P Tekkis
Journal:  Clin Exp Metastasis       Date:  2012-11-23       Impact factor: 5.150

5.  Slow proliferation as a biological feature of colorectal cancer metastasis.

Authors:  A Anjomshoaa; S Nasri; B Humar; J L McCall; A Chatterjee; H-S Yoon; L McNoe; M A Black; A E Reeve
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.